Skip to content

The Efficacy of Topical Minocycline in Managing Symptomatic Oral Lichen Planus

The Efficacy of Topical Minocycline in Managing Symptomatic Oral Lichen Planus. A Randomized Controlled Trial

Status
UNKNOWN
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01083420
Enrollment
30
Registered
2010-03-09
Start date
2010-03-31
Completion date
2012-03-31
Last updated
2010-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral Lichen Planus

Keywords

Oral lichen planus, Minocycline, Dexamethasone

Brief summary

The aim of the present study is to assess the clinical efficacy of topical minocyclin in managing of symptoms associated with oral lichen planus (OLP). The rationale of the study is based on our previous studies demonstrating the beneficial effect of minocyclin mouthwash on recurrent aphthous stomatitis. The planned study will be a randomized controlled, cross-over trail. Patients with symptomatic OLP will randomly receive minocycline or dexamethasone rinses. The patients will rinse and expectorate 5 ml of the 1st mouthwash 4 times daily for 14 days. Subjects will complete a daily follow-up form that includes data regarding the daily intensity of pain (using VAS) caused by OLP and regarding possible side effects. After a washout period (at least 14 days) the patients will repeat the protocol with the second mouthwash.

Interventions

DRUGMinocycline

Minocycline 0.2% mouthwash

DRUGDexamethasone

Dexamethasone 0.01% mouthwash

Sponsors

Sheba Medical Center
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* OLP patients (Biopsy proven)

Exclusion criteria

* Known allergy to Dexamethasone or Minocycline * Pregnancy

Design outcomes

Primary

MeasureTime frame
symptoms relief2 years

Contacts

Primary ContactNoam Yarom, DMD
noamyar@post.tau.ac.il+972-3-5303819

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026